June 6 (UPI) -- A new vaccine to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.
If approved, the shot -- lenacapavir -- would be given twice a year and could be a big step forward in the fight against HIV.
Drugmaker Gilead Sciences tested the shot in a study of women and girls. None of the participants who received the injections got HIV.
That early success helped boost Gilead's stock by 73% over the past year, The Wall Street Journal reported.
Related
